Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

A Monocular SLAM-based Controller for Multirotors with Sensor Faults under Ground Effect.

Matus-Vargas A, Rodriguez-Gomez G, Martinez-Carranza J.

Sensors (Basel). 2019 Nov 13;19(22). pii: E4948. doi: 10.3390/s19224948.

2.

The earliest cut marks of Europe: a discussion on hominin subsistence patterns in the Orce sites (Baza basin, SE Spain).

Espigares MP, Palmqvist P, Guerra-Merchán A, Ros-Montoya S, García-Aguilar JM, Rodríguez-Gómez G, Serrano FJ, Martínez-Navarro B.

Sci Rep. 2019 Oct 28;9(1):15408. doi: 10.1038/s41598-019-51957-5.

3.

Diego Rivera, The History of Medicine in Mexico: Peopled Demand for Better Health, mural in 1953 still current.

Rodríguez-Gómez G, Cabello FC.

Rev Chil Pediatr. 2019 Jun;90(3):351-355. doi: 10.32641/rchped.v90i3.1085.

4.

Neandertal growth: what are the costs?

Mateos A, Goikoetxea I, Leonard WR, Martín-González JÁ, Rodríguez-Gómez G, Rodríguez J.

J Hum Evol. 2014 Dec;77:167-78. doi: 10.1016/j.jhevol.2014.09.003. Epub 2014 Oct 18.

PMID:
25439708
5.

Discontinuity of human presence at Atapuerca during the early Middle Pleistocene: a matter of ecological competition?

Rodríguez-Gómez G, Mateos A, Martín-González JA, Blasco R, Rosell J, Rodríguez J.

PLoS One. 2014 Jul 23;9(7):e101938. doi: 10.1371/journal.pone.0101938. eCollection 2014.

6.

Modeling trophic resource availability for the first human settlers of Europe: the case of Atapuerca TD6.

Rodríguez-Gómez G, Rodríguez J, Martín-González JÁ, Goikoetxea I, Mateos A.

J Hum Evol. 2013 Jun;64(6):645-57. doi: 10.1016/j.jhevol.2013.02.007. Epub 2013 Mar 28.

PMID:
23541385
7.

[Attentional neural networks impairment in healthy aging].

Vázquez-Marrufo M, Luisa Benítez M, Rodríguez-Gómez G, Galvao-Carmona A, Fernández-Del Olmo A, Vaquero-Casares E.

Rev Neurol. 2011 Jan 1;52(1):20-6. Spanish.

8.

Frequency of increased aminotransferases levels and associated metabolic abnormalities in obese and overweight children of an elementary school in Mexico City.

Flores-Calderón J, Gómez-Díaz RA, Rodríguez-Gómez G, Morán-Villota S.

Ann Hepatol. 2005 Oct-Dec;4(4):279-83.

9.

Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone.

Baumgartner RA, Martinez G, Edelman JM, Rodriguez Gomez GG, Bernstein M, Bird S, Angner R, Polis A, Dass SB, Lu S, Reiss TF; Montelukast Asthma Study Group.

Eur Respir J. 2003 Jan;21(1):123-8.

10.

Single-dose miconazole nitrate vaginal ovule in the treatment of vulvovaginal candidiasis: two single-blind, controlled studies versus miconazole nitrate 100 mg cream for 7 days.

Upmalis DH, Cone FL, Lamia CA, Reisman H, Rodriguez-Gomez G, Gilderman L, Bradley L.

J Womens Health Gend Based Med. 2000 May;9(4):421-9.

PMID:
10868615
11.

Efficacy of twice-daily amoxycillin/clavulanate in lower respiratory tract infections.

Balgos AA, Rodriguez-Gomez G, Nasnas R, Mahasur AA, Margono BP, Tinoco-Favila JC, Sansores-Martinez RH, Hassan M, Beppo O, Wongsa A, Cukier A, Vargas F.

Int J Clin Pract. 1999 Jul-Aug;53(5):325-30.

PMID:
10695094
12.

The Costa Rican emergency medicine residency: design and implementation of a new specialty training program in Central America.

Keyes C, Rodríguez-Gomez G, Quesada-Rodriguez D, Waller J.

Ann Emerg Med. 1999 Dec;34(6):790-5.

PMID:
10577412
13.

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.

Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Piñeiro A, Wei LX, Seidenberg BC, Reiss TF.

Ann Intern Med. 1999 Mar 16;130(6):487-95.

PMID:
10075616
14.

Comparative Effects of Ceftazidime Two or Three Times Daily in Patients with Skin and Skin Structure Infections.

Gentry LO, Rodriguez-Gomez G, Pien F, Cubeddu L, Holley HP Jr, Buaron K, Giguere G, Collins JJ.

Am J Ther. 1996 Mar;3(3):212-218.

PMID:
11862252
15.

Ofloxacin treatment of difficult infections of the skin and skin structure.

Gentry LO, Rodriguez-Gomez G.

Cutis. 1993 Jan;51(1):55-8.

PMID:
8419113
16.

Multicenter open-label study of parenteral ofloxacin in treatment of pyelonephritis in adults.

Cox CE, Gentry LO, Rodriguez-Gomez G.

Urology. 1992 May;39(5):453-6.

PMID:
1580038
17.

Oral ofloxacin therapy for lower respiratory tract infection.

Gentry LO, Lipsky B, Farber MO, Tucker B, Rodriguez-Gomez G.

South Med J. 1992 Jan;85(1):14-8.

PMID:
1734527
18.

Parenteral followed by oral ofloxacin for nosocomial pneumonia and community-acquired pneumonia requiring hospitalization.

Gentry LO, Rodriguez-Gomez G, Kohler RB, Khan FA, Rytel MW.

Am Rev Respir Dis. 1992 Jan;145(1):31-5.

PMID:
1731595
20.

Ofloxacin versus parenteral therapy for chronic osteomyelitis.

Gentry LO, Rodriguez-Gomez G.

Antimicrob Agents Chemother. 1991 Mar;35(3):538-41.

21.

A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections.

Gentry LO, Rodriguez-Gomez G, Zeluff BJ, Khoshdel A, Price M.

Am J Med. 1989 Dec 29;87(6C):57S-60S.

PMID:
2690621

Supplemental Content

Loading ...
Support Center